<--- Back to Details
First PageDocument Content
Medicine / Immunology / Clinical medicine / Monoclonal antibodies / Immunosuppressants / Immune system / Biotechnology / Infliximab / Daclizumab / TNF inhibitor / Adalimumab / Rheumatology
Date: 2015-06-19 09:19:09
Medicine
Immunology
Clinical medicine
Monoclonal antibodies
Immunosuppressants
Immune system
Biotechnology
Infliximab
Daclizumab
TNF inhibitor
Adalimumab
Rheumatology

TABLE OF CONTENTS INTRODUCTION 2

Add to Reading List

Source URL: www.abirisk.eu

Download Document from Source Website

File Size: 770,06 KB

Share Document on Facebook

Similar Documents

SCIENCE AND FIBROMYALGIA A Review of Recent Research for Fibromyalgia Awareness Day, May 12, 1999 In February of this year, an article in a scientific journal announced the discovery that a new immune system antibody had

DocID: 1vs8m - View Document

Reprogramming the Immune System for the Establishment of ToleranceIntegrating European research on immune tolerance: a key step to build a better future for transplanted patients.

DocID: 1vrpL - View Document

4 Original Article Computational Ensemble Approach for Immune System Study: Conformational B-cell Epitope Prediction

DocID: 1vinS - View Document

THE CANCER REVOLUTION Additional Material for Appendix 1 Francisco Contreras, MD and Daniel Kennedy Contreras Dendritic cell cancer vaccine The most powerful anti-cancer agent is the immune system. In fact, it’s imposs

DocID: 1vfY6 - View Document

Applications of Immune System Computing Ricardo Hoar What kind of applications?

DocID: 1vaZn - View Document